Merck & Co., Inc. (NYSE:MRK) will report its next earnings on 2-Feb-17. The company reported the earnings of $1.07/Share in the last quarter where the estimated EPS by analysts was $0.99/share. The difference between the expected and actual EPS was $0.08/share, which represents an Earnings surprise of 8.1%.

Many analysts are providing their Estimated Earnings analysis for Merck & Co., Inc. and for the current quarter 17 analysts have projected that the stock could give an Average Earnings estimate of $0.89/share. These analysts have also projected a Low Estimate of $0.84/share and a High Estimate of $0.96/share.

In case of Revenue Estimates, 14 analysts have provided their consensus Average Revenue Estimates for Merck & Co., Inc. as 10.23 Billion. According to these analysts, the Low Revenue Estimate for Merck & Co., Inc. is 10 Billion and the High Revenue Estimate is 10.51 Billion. The company had Year Ago Sales of 10.22 Billion.

Some buy side analysts are also providing their Analysis on Merck & Co., Inc., where 3 analysts have rated the stock as Strong buy, 8 analysts have given a Buy signal, 11 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 19 Analysts reported that the Price Target for Merck & Co., Inc. might touch $82 high while the Average Price Target and Low price Target is $68.32 and $60 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Merck & Co., Inc. got Upgrade on 13-Oct-16 where investment firm BofA/Merrill Upgrade the stock from Neutral to Buy.

Merck & Co., Inc. closed its last trading session at $61.8 with the gain of 0.63%. The Market Capitalization of the company stands at 171.47 Billion. The Company has 52-week high of $65.46 and 52-week low of $47.97. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 0.98% where SMA50 and SMA200 are 0.51% and 7.98% respectively. The Company Touched its 52-Week High on Nov 10, 2016 and 52-Week Low on Feb 8, 2016.

The Relative Volume of the company is 0.89 and Average Volume (3 months) is 10.39 million. Merck & Co., Inc. P/E (price to earnings) ratio is 31.63 and Forward P/E ratio of 16.01.

The company shows its Return on Assets (ROA) value of 5.6%. The Return on Equity (ROE) value stands at 12.5%. While it’s Return on Investment (ROI) value is 6.4%.

While looking at the Stock’s Performance, Merck & Co., Inc. currently shows a Weekly Performance of -0.18%, where Monthly Performance is 5.69%, Quarterly performance is -0.1%, 6 Months performance is 12.12% and yearly performance percentage is 21.22%. Year to Date performance value (YTD perf) value is 20.62%. The Stock currently has a Weekly Volatility of 1.63% and Monthly Volatility of 1.60%.